Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002049793-25-000001·Solas Tvardi Sidecar LLC
Schedule 13G ownership disclosure
CARA THERAPEUTICS INC
Common Stock of Tvardi Therapeutics, Inc. · CUSIP: 140755208
Event date: 2025-04-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Solas Tvardi Sidecar LLC
Shares: 761,287.00 · Class: 8.1%
- Solas BioVentures Fund II, LP
Shares: 761,287.00 · Class: 8.1%
- Solas Partners II, LLC
Shares: 761,287.00 · Class: 8.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002049793-25-000001
- Form type
- SCHEDULE 13G
- Filer
- Solas Tvardi Sidecar LLC
- CIK
- CIK 2049793
- Filed
- Apr 22, 2025
- Reporting period
- Apr 15, 2025
- Description
- Schedule 13G beneficial ownership